At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03759 PHARMARON
Trading 12-23 13:43:10
13.980
+0.260
+1.90%
High14.120
Low13.660
Vol3.16M
Open13.760
D1 Closing13.720
Amplitude3.35%
Mkt Cap24.95B
Tradable Cap4.18B
Total Shares1.79B
T/O44.05M
T/O Rate1.06%
Tradable Shares299.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Hong Kong Stocks Extends Gains; NetEase and Meituan Jump 6%; Alibaba and JD.com Gain 4%
Pharmaron Beijing Co Ltd is a China-based company providing research and manufacturing service portfolio, medical tools and clinical research testing services in the process of discovering, developing and manufacturing small molecule drugs, cell therapy and gene therapy. The Company operates in four segments. Laboratory Services segment includes laboratory chemistry, drug metabolism and pharmacokinetics/absorption, distribution, metabolism and excretion, biology, safety assessment and discovery of biological agents. CMC Service segment is engaged in process development and preform production and analysis. Clinical Development Service segment includes clinical research, on-site management organization, regulatory biological analysis and radioactive labeling scientific services. The Biologics and CGT Services segment is engaged in the discovery, development and production of macromolecular drugs, development of cell gene therapy methods and other businesses.